Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Anaesthesist ; 54(5): 427-41, 2005 May.
Artículo en Alemán | MEDLINE | ID: mdl-15815886

RESUMEN

Due to the increasing age in western countries, combined with high rates of major surgical interventions in high-risk patients, perioperative reduction of cardiovascular complications becomes increasingly more important for perioperative physicians. After identifying patients with increased perioperative risk, specific interventions need to be considered to reduce their risk for cardiovascular complications, either by perioperative medical therapy or specific treatment options (e.g. coronary intervention). Several trials have demonstrated an effect of perioperative beta-blocker-therapy in reducing cardiovascular complications among high-risk patients. Additionally, several monitoring techniques are effective in detecting cardiovascular complications. Nevertheless, it remains unclear whether they are associated with a measurable improvement of outcome. Based on the ACC/AHA-guidelines, the present review describes a stepwise approach to surgical patients to identify perioperative risks, based on specific patient related risk factors, the kind of surgery and on the specific setting (emergency versus elective surgery). In addition, strategies to reduce perioperative cardiovascular complications are discussed.


Asunto(s)
Enfermedades Cardiovasculares/complicaciones , Atención Perioperativa , Cuidados Preoperatorios , Enfermedades Cardiovasculares/fisiopatología , Electrocardiografía , Humanos , Monitoreo Intraoperatorio , Infarto del Miocardio/fisiopatología , Revascularización Miocárdica , Riesgo , Medición de Riesgo
3.
J Autoimmun ; 15(4): 479-84, 2000 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-11090247

RESUMEN

Autoantibodies against neuronal and tumour proteins have been described in many paraneoplastic neurological syndromes (PNS), but it is not clear whether these antibodies are pathogenic or simply a useful diagnostic tool. We took seven sera that were positive on routine screening for antineuronal antibodies and the IgG fractions. As controls we used sera from health blood-donors, other neurological autoimmune diseases and patients with SCLC without PNS. We tested them on dissociated rat myenteric plexus cultures for cytotoxic effects. After incubation for 24 h, cytotoxicity was determined by a double fluorescence test (calcein green for living cells and ethidium homodimer-1 for dead cells). We found an increased cell death rate in cultures incubated with the PNS sera, compared with all controls (P< 0.05). Isolated IgG fractions were also cytotoxic whereas the IgG-free serum fraction did not show any significant increase in cytotoxicity. After incubation with PNS IgG, FACS analysis revealed an increased cytotoxicity rate only of the neurones, but not the glial cells. Our results indicate that in PNS a complement-independent, antibody-mediated cytotoxicity against neurones may contribute to the pathogenesis of these syndromes.


Asunto(s)
Autoanticuerpos/inmunología , Citotoxicidad Inmunológica , Inmunoglobulina G/inmunología , Plexo Mientérico/inmunología , Enfermedades del Sistema Nervioso/etiología , Síndromes Paraneoplásicos/etiología , Animales , Western Blotting , Humanos , Inmunohistoquímica , Enfermedades del Sistema Nervioso/inmunología , Síndromes Paraneoplásicos/inmunología , Ratas
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA